ADVFN - Advanced Financial Network.
HOME» NASDAQ » N » NUVA Stock Price » NUVA Stock News

Nuvasive Share News

 Nuvasive (mm) Stock Price
NUVA Stock Price
 Nuvasive (mm) Stock Chart
NUVA Stock Chart
 Nuvasive (mm) Stock News
NUVA Stock News
 Nuvasive (mm) Company Information
NUVA Company Information
 Nuvasive (mm) Stock Trades
NUVA Stock Trades

Spinal-Device Makers Report Rising Pressure From Insurers

By Jon Kamp Of DOW JONES NEWSWIRES After several quarters of flagging sales, big makers of spinal devices have started reporting a new source of pressure on the $7.1 billion market: insurance companies. Health insurers have long raised hurdles for various spinal procedures, but they appear to be ramping up these efforts, particularly when it comes to spinal-fusion surgery amid insurers' views that such procedures are overused. Some of the spine industry's biggest companies--Johnson & Johnson (JNJ), Stryker Corp. (SYK), Swiss firm Synthes Inc. (SYST.VX) and Zimmer Holdings Inc. (ZMH)--all recently signaled pressure on reimbursements as a factor behind the market's doldrums. The comments came on second-quarter earnings calls, where they joined declining product prices as an explanation for slowing sales growth. "We see this as a noticeable change in message and a concerning sign of potential further procedure softness to come," said Derrick Sung, an analyst with Sanford Bernstein. Factoring in expected results for industry heavyweight Medtronic Inc. (MDT), which doesn't report fiscal-quarter results until later this month, Sung estimated spinal-market sales grew about 3% in the second quarter, excluding the effect of currency rates. This continues a slide for a market Sung estimated grew 14% in the second quarter last year. The effect isn't universal, because smaller companies with newer and less-invasive offerings like NuVasive Inc. (NUVA) continue growing rapidly, indicating market share losses are another factor hurting big competitors. Manufacturers have offered limited details, so it's tough to discern the degree to which slowing procedure growth is causing problems. But insurers are indeed pushing back, and the pressure is growing, said Frank Cammisa, Jr., a surgeon and chief of the Spine Service at the Hospital for Special Surgery in New York City. Spinal problems can be complicated and hard to categorize, he cautioned, which creates an opening to raise questions about whether procedures are appropriate. More straightforward orthopedic procedures, such as replacement hip surgery, don't have the same gray area, and aren't questioned as much. "Spine is complex, there are so many variables, [and] it's hard to make blanket statements," Cammisa said. He feels patients who need surgery at his hospital still get it. But patients elsewhere who arguably don't need surgery, yet were headed in that direction anyway, may be nudged off course. WellPoint Inc. (WLP), for example, has rolled out a video program that helps patients review options, including non-surgical treatments, and has hired a cadre of surgeons that "engage the doctor and have a dialogue" when spine-surgery requests come in, said Anthony Nguyen, senior vice president of care management at WellPoint. Backed by these methods, he said 25% to 55% of pre-authorization requests for spinal fusion--which involves an array of instruments and tools used to access the spine and fuse vertebrae--are somehow modified. This means patients get some other type of procedure, the requests are withdrawn or the requests are denied. The company's research unit issued a study last year that said many people with back pain get imaging tests and have surgery "much earlier than recommended by national guidelines on back pain." It's not surprising this type of surgery has caught insurers' eye, as the government's Agency for Healthcare Research and Quality has identified spinal fusion as a top cause of increasing in-patient hospital expenses. In a span between 2004 and 2007, costs for spinal fusion rose nearly twice as fast as the rate of hospital stays, indicating procedures got more expensive as they became more common. Aetna Inc. (AET) requires pre-certification for patients getting lower-back spinal fusion; a spokeswoman said factors that put procedures on this list include "the likelihood of inappropriate utilization, and practical considerations regarding implementation." Synthes specifically called out reimbursement rejections for lower back surgery in the U.S. as an issue. Cammisa said minimally invasive procedures to fix spinal compression fractures have also come under pressure from insurers following articles in a major medical journal last year that questioned their efficacy, although he disagreed with that conclusion. UnitedHealth Inc. (UNH) rolled out a program in several states earlier this year that aims to reduce "unnecessary spine surgeries," according to company documents on the plan. The so-called spine surgery influence model is an education-based program that aims to "promote physician discussion around providing spinal care consistent with nationally developed guidelines," the company said. It won't deny coverage based on this process, but analyst Sung thinks insurers' efforts could escalate from here. "That's kind of the first shot across the bow," he said. "What it tells me is it's on the radar screen." -By Jon Kamp, Dow Jones Newswires; 617-654-6728;

Stock News for Nuvasive (NUVA)
01/15/201409:06:21U.S. Hot Stocks: Hot Stocks to Watch
11/15/201308:55:37Highbridge Capital Management 3Q 13F: Largest Eliminations
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Purchases
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Sales
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest -2-
11/14/201307:21:26GAMCO Asset Management Inc. 3Q 13F: Largest -2-
11/14/201307:21:26GAMCO Asset Management Inc. 3Q 13F: Largest Purchases
06/12/201307:13:48NuVasive to Raise Litigation Expense After Medtronic Royalty...
10/04/201213:16:23NuVasive Shares Plunge as Customers, Sales Defect to Competitors
06/28/201212:15:42Hospitals Surge, Insurers Slide as Health-Care Law is Upheld
01/27/201213:42:21Judge Affirms Rulings Denying Medtronic, NuVasive Motions
01/25/201216:34:24Court Denies Medtronic, NuVasive Motions Ahead of Hearing Thursday
05/04/201118:58:26NuVasive 1Q Earnings Jump; Sees Signs Of Stabilization In Spinal-Device...
04/27/201116:40:18J&J Gains Orthopedic Heft With Synthes But Faces Challenges
01/28/201116:41:27Insurer Clarifies Policy, Seen As Win For Spinal Device Makers
01/18/201117:50:48NuVasive Says Cigna, Humana Back Spine Procedure; Shares Rise
12/22/201017:15:14Medical Groups Take Issue With Insurers' Spine Surgery Rule
12/01/201012:17:16NuVasive CEO Backs Views Of Spinal-Market Pressure, Outlook

Nuvasive and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations